Bioscientia International

What Bioscientia International does

Bioscientia International is a German medical laboratory network founded in March 1970 as a joint venture between Boehringer Ingelheim and Bioscience Labs (USA), now operating as part of Australia's Sonic Healthcare group since its September 2007 acquisition. Following the January 2019 merger of the Bioscientia Group with the Sonic-owned Labdiagnostics Group under the Bioscientia Healthcare GmbH holding, the combined entity runs 19 laboratory locations across Germany, employs approximately 2,500 staff (including 100+ doctors and 200+ natural scientists), and reports annual sales of approximately €280 million.

The company is structured around three core divisions. The Diagnostics division offers laboratory testing across 13 specialty areas (blood, brain and nerves, healthy pregnancy, heart and circulation, kidneys and urinary tract, lifestyle, liver, lungs, metabolism and hormones, prevention, sexual medicine, stomach and intestines, and teeth). The Genetics division delivers comprehensive genetic testing across 24 indication categories using methods including cytogenetics, FISH, CMA/Array-CGH, optical genome mapping, long-read sequencing (PacBio HiFi), gene panels, NIPT, short-read sequencing with MLPA, and single-gene analyses. The Centre for Hygiene and Infection Prevention (ZHI) provides hygiene diagnostics, water and Legionella testing (DAkkS-accredited), food hygiene services, and a CRE Competence Centre. The Bio.net Report-App provides a digital access layer for physicians to retrieve results on mobile and web, with push notifications for urgent findings. Pathology, dental diagnostics, and microbiome analysis round out the service portfolio.

Bioscientia sells B2B diagnostic services primarily through a direct sales force across its 19 German laboratories, serving hospitals, university institutes, private clinics, physician practices, government clients (including ministries of defence and health), corporate clients, dental practices, and veterinary clinics. International expansion operates through an agent network across Bahrain, Egypt, Ethiopia, Jordan, Kuwait, Lebanon, Libya, Qatar, Saudi Arabia, and the UAE, anchored by a regional HQ in Hazmieh, Lebanon. Revenue is generated predominantly through per-test fees billed to healthcare providers, complemented by per-unit hygiene testing (e.g., €38.59 per water treatment unit, €80.52 per dishwasher test). The company holds an unusually deep accreditation stack — CAP (since 1987, the first German laboratory accredited), CLIA, DAkkS to ISO 17025 and ISO 15189, and ZLG certification — which functions as a regulatory moat in German and international clinical diagnostics.

Name

Bioscientia International

Legal name

Bioscientia Healthcare GmbH

Website

https://bioscientia.com

Company type

Private

Founded year

1970

Operating status

Operating

Headcount range

11–50 employees

Short description

Bioscientia International is a German medical laboratory network (part of Sonic Healthcare) operating 19 labs across Germany with ~2,500 employees and ~€280M annual revenue. It delivers clinical diagnostics, genetic testing, and hygiene/infection-prevention services to hospitals, physicians, government, and international clients in the Middle East and Africa.

Ownership category

akta.pro rank

Product category

Medical Laboratory Diagnostics

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)

Keywords

• Medical laboratory diagnostics
• Clinical pathology services
• Genetic testing services
• Hygiene infection prevention
• Molecular diagnostics

Headquarters

HQ city

Ingelheim

HQ country

Germany

HQ region

Europe

Offices19 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Laboratory Diagnostic Services: B2B laboratory testing services for healthcare providers including clinical chemistry, molecular diagnostics, genetic testing, and specialized diagnostic panels. Revenue generated through test processing fees billed to hospitals, clinics, physician practices, and government healthcare facilities.
2. Hygiene Testing Services: Microbiological testing services for dental practices and clinics including water testing, sterilizer validation, and dishwasher testing. Priced per test unit.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Bioscientia International is a German medical laboratory diagnostics provider operating a network of 19 laboratories across Germany. The company offers routine clinical chemistry, immunology, microbiology, molecular diagnostics, genetics, pathology, hygiene/infection prevention testing, and dental diagnostics for hospitals, clinics, physician practices, and government public-health clients. It serves as a one-stop diagnostic partner with international reach through an agency network covering the Middle East and Africa.

Product overview

Bioscientia International is a network of medical laboratories operating as a unified platform with three core divisions: Diagnostics, Genetics, and the Centre for Hygiene and Infection Prevention (ZHI). The Diagnostics division provides laboratory testing across 13 specialty areas (Blood, Brain & nerves, Healthy pregnancy, Heart & circulation, Kidneys & urinary tract, Lifestyle, Liver, Lungs, Metabolism & hormones, Prevention, Sexual medicine, Stomach & intestines, Teeth) delivered via a centralized network of 19 locations. The Genetics division offers comprehensive genetic testing across 24 indication categories using methods including Cytogenetics, FISH, CMA/Array-CGH, Optical Genome Mapping, Long-Read Sequencing, Gene Panels, NIPT, Short-Read Sequencing/MLPA, and Single Gene Analyses. The Hygiene division (ZHI) provides hygiene diagnostics, food hygiene testing, water and Legionella diagnostics, and a CRE Competence Centre. The Bio.net Report-App serves as the digital access layer for all divisions, enabling physicians to retrieve results on mobile and web. A Pathology service adds histopathology, molecular pathology, and EndoPredict testing. All divisions share centralized services including Quality Management, Sampling and Shipping, Publications, and the Bio.net reporting platform.

Differentiator

Problem solved

Functional benefit

Brands

• Diagnostics: Main laboratory diagnostics division offering tests across various medical disciplines including blood, brain, heart, kidneys, liver, lungs, metabolism, prevention, sexual medicine, stomach/intestines, and teeth.
• Genetics
• Hygiene (ZHI)

Products and services

• Laboratory Diagnostics (Routine Clinical Diagnostics) Core routine laboratory diagnostic service covering clinical chemistry, immunology, hematology, and microbiology for hospitals, clinics, and physician practices across Germany.
• Bioscientia Genetics Specialised human genetics laboratory offering cytogenetics, FISH, CMA/Array-CGH, MLPA, and next-generation sequencing (NGS) for hereditary disease diagnostics, targeted to clinicians and genetic counselors.
• Bio.net Report-App Digital application providing ordering, tracking, and digital delivery of laboratory test results to referring physicians and practices.
• Centre for Hygiene and Infection Prevention (ZHI) Specialised hygiene testing, microbiological surveillance, and infection-prevention consultation service for hospitals, clinics, and public-health bodies.
• Pathology Services Tissue-based histopathology and cytopathology diagnostic service for hospital pathology departments, surgeons, and outpatient specialists.
• Dental Diagnostics Dedicated laboratory diagnostic service for dental practices, including microbiology, genetic susceptibility testing, and hygiene assessment.
• Intestinal Microbiome Analysis Molecular gut-microbiome profiling service using next-generation sequencing, offered to gastroenterologists, nutritionists, and preventive-medicine practitioners.

Quantifiable outcome

• Free sample shipment within Germany
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• Quest Diagnostics: US-headquartered global clinical laboratory network offering diagnostics, advanced genetics, and employer/health plan services. Comparable in scale of routine diagnostics and genetics, and competes in CAP-accredited international reference work.
• Sonic Healthcare: Australian-listed global laboratory network and Bioscientia's parent company; directly comparable in clinical chemistry, molecular diagnostics, and anatomic pathology across Germany, Europe, Australia, and the US, with Sonic's German operations being the closest overlap.
• Cerba HealthCare: International clinical laboratory network offering routine and specialty diagnostics across Europe, including genetics. Comparable to Bioscientia on advanced testing (especially genetics/oncology) and competes in cross-border hospital and pharma services.
• Labcorp: US-headquartered global clinical laboratory network offering diagnostics, genetics, and drug development services. While primarily North American, it competes with Bioscientia's genetics division in advanced methods and pharma/biotech contract work.

Emerging players

• Eurofins Scientific: International bioanalytical testing group with growing clinical diagnostics footprint, including genomics. Overlaps with Bioscientia's hygiene (water/Legionella) and genetics services, though Eurofins is broader in environmental and pharma testing.

Direct peers

• amedes Group: German clinical laboratory network with strong MVZ presence offering diagnostics, genetics, and specialty testing; the previous employer of Bioscientia's CEO Dr. Harzer, and a direct German-market competitor with comparable KV-regulated lab footprint.
• Synlab: Europe's largest clinical laboratory operator offering medical diagnostics, genetics, and specialty testing across 30+ countries with significant overlap with Bioscientia's Diagnostics, Genetics, and Hygiene service lines. Synlab is the closest competitor in the German and broader European market.
• LADR Der Laborverbund: German network of regional medical laboratories providing clinical chemistry, microbiology, and specialty diagnostics. Directly competes with Bioscientia for German hospital and physician referrals and operates a comparable regional multi-site model.
• Limbach Group: German laboratory network (~30 labs nationwide) offering clinical diagnostics, genetics, and specialty testing. COO Frank Exner previously worked at Limbach, and Limbach is a direct German competitor with overlapping test menu and KV-regulated reimbursement model.
• Unilabs: Major European clinical laboratory network offering diagnostics, genetics, and specialty testing across ~30 countries. Directly competes with Bioscientia for cross-border hospital and physician referrals, particularly in Middle East markets where both have presence.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bioscientia-international

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioscientia International